Skip to main content Accessibility help
×
Home

Risk of progression from mild memory impairment to clinically diagnosable Alzheimer's disease in a Japanese community (from the Nakayama Study)

  • Naomi Sonobe (a1), Ryuji Hata (a1) (a2), Tomohisa Ishikawa (a1), Kantaro Sonobe (a1), Teruhisa Matsumoto (a1), Yasutaka Toyota (a1), Takaaki Mori (a1), Ryuji Fukuhara (a1), Kenjiro Komori (a1), Shu-ichi Ueno (a1), Satoshi Tanimukai (a1) and Manabu Ikeda (a3)...

Abstract

Background: Memory impairment has been proposed as the most common early sign of Alzheimer's disease (AD). The aims of this work were to evaluate the risk of progression from mild memory impairment/no dementia (MMI/ND) to clinically diagnosable AD in a community-based prospective cohort and to establish the risk factors for progression from MMI/ND to AD in the elderly.

Methods: Elderly subjects aged over 65 years were selected from the participants in the first Nakayama study. MMI/ND was defined as memory deficit on objective memory assessment, without dementia, impairment of general cognitive function, or disability in activities of daily living. A total of 104 MMI/ND subjects selected from 1242 community-dwellers were followed longitudinally for five years.

Results: During the five-year follow-up, 11 (10.6%) subjects were diagnosed with AD, five (4.8%) with vascular dementia (VaD), and six (5.8%) with dementia of other etiology. Logistic regression analysis revealed that diabetes mellitus (DM) and a family history of dementia (within third-degree relatives) were positively associated with progression to AD, while no factor was significantly associated with progression to VaD or all types of dementia.

Conclusions: DM and a family history of dementia were significant risk factors for progression from MMI/ND to clinically diagnosable AD in the elderly in a Japanese community.

Copyright

Corresponding author

Correspondence should be addressed to: Ryuji Hata, MD, PhD, Department of Functional Histology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan. Phone: + 81 89960 5236; Fax: + 81 89960 5239. Email: hata@m.ehime-u.ac.jp.

References

Hide All
Ahtiluoto, S. et al. (2010). Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology, 75, 11951202.
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. Washington, DC: American Psychiatric Association.
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A. and Bennett, D. A. (2004). Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Archives of Neurology, 61, 661666.
Bendlin, B. B. et al. (2010). Midlife predictors of Alzheimer's disease. Maturitas, 65, 131137.
Biessels, G. J., De Leeuw, F. E., Lindeboom, J., Barkhof, F. and Scheltens, P. (2006). Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus. Journal of Neurology, Neurosurgery and Psychiatry, 77, 304307.
Burns, A. and O'Brien, J. (2006). Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. Journal of Psychopharmacology, 20, 732755.
Chen, J. H., Lin, K. P. and Chen, Y. C. (2009). Risk factors for dementia. Journal of the Formosan Medical Association, 108, 754764.
Farias, S. T., Mungas, D., Reed, B. R., Harvey, D. and DeCarli, C. (2009). Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Archives of Neurology, 66, 11511157.
Gasparini, L. and Xu, H. (2003). Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends in Neurosciences, 26, 404406.
Gatz, M. et al. (2005). Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study. Neurobiology of Aging, 26, 439447.
Gauthier, S. et al. (2006). Mild cognitive impairment. The Lancet, 367, 12621270.
Heun, R., Kolsch, H. and Jessen, F. (2006). Risk factors and early signs of Alzheimer's disease in a family study sample: risk of AD. European Archives of Psychiatry and Clinical Neuroscience, 256, 2836.
Hulette, C. M., Welsh-Bohmer, K. A., Murray, M. G., Saunders, A. M., Mash, D. C. and McIntyre, L. M. (1998). Neuropathological and neuropsychological changes in “normal” aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. Journal of Neuropathology and Experimental Neurology, 57, 11681174.
Ikeda, M. et al. (2001). Increased prevalence of vascular dementia in Japan: a community-based epidemiological study. Neurology, 57, 839844.
Ishikawa, T., Ikeda, M., Matsumoto, N., Shigenobu, K., Brayne, C. and Tanabe, H. (2006). A longitudinal study regarding conversion from mild memory impairment to dementia in a Japanese community. International Journal of Geriatric Psychiatry, 21, 134139.
Kirshner, H. S. (2009). Vascular dementia: a review of recent evidence for prevention and treatment. Current Neurology and Neuroscience Reports, 9, 437442.
Kodl, C. T. and Seaquist, E. R. (2008). Cognitive dysfunction and diabetes mellitus. Endocrine Reviews, 29, 494511.
Luck, T., Luppa, M., Briel, S. and Riedel-Heller, S. G. (2010). Incidence of mild cognitive impairment: a systematic review. Dementia and Geriatric Cognitive Disorders, 29, 164175.
MacKnight, C., Rockwood, K., Awalt, E. and McDowell, I. (2002). Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dementia and Geriatric Cognitive Disorders, 14, 7783.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939944.
Meyer, J. S., Xu, G., Thornby, J., Chowdhury, M. H. and Quach, M. (2002). Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease? Stroke, 33, 19811985.
Mitchell, A. J. and Shiri-Feshki, M. (2009). Rate of progression of mild cognitive impairment to dementia: meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica, 119, 252265.
Mohs, R. C. et al. (2001). A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology, 57, 481488.
Mosconi, L. et al. (2010). Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. Proceedings of the National Academy of Sciences of the United States of America, 107, 59495954.
O'Brien, J. T. et al. (2003). Vascular cognitive impairment. The Lancet Neurology, 2, 8998.
Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256, 183194.
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303308.
Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L. and DeKosky, S. T. (2001). Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 11331142.
Qiu, W. Q. and Folstein, M. F. (2006). Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Neurobiology of Aging, 27, 190198.
Román, G. C. et al. (1993). Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43, 250260.
Roriz-Filho, J. S. et al. (2009). (Pre)diabetes, brain aging, and cognition. Biochimica et Biophysica Acta, 5, 432443.
Schneider, J. A., Aggarwal, N. T., Barnes, L., Boyle, P. and Bennett, D. A. (2009). The neuropathology of older persons with and without dementia from community versus clinic cohorts. Journal of Alzheimer's Disease, 18, 691701.
Stephan, B. C., Matthews, F. E., Khaw, K. T., Dufouil, C. and Brayne, C. (2009). Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). Alzheimer's Research and Therapy, 1, 4.
Viswanathan, A., Rocca, W. A. and Tzourio, C. (2009). Vascular risk factors and dementia: how to move forward? Neurology, 72, 368374.
Yesavage, J. A. (1988). Geriatric Depression Scale. Psychopharmacology Bulletin, 24, 709711.

Keywords

Related content

Powered by UNSILO

Risk of progression from mild memory impairment to clinically diagnosable Alzheimer's disease in a Japanese community (from the Nakayama Study)

  • Naomi Sonobe (a1), Ryuji Hata (a1) (a2), Tomohisa Ishikawa (a1), Kantaro Sonobe (a1), Teruhisa Matsumoto (a1), Yasutaka Toyota (a1), Takaaki Mori (a1), Ryuji Fukuhara (a1), Kenjiro Komori (a1), Shu-ichi Ueno (a1), Satoshi Tanimukai (a1) and Manabu Ikeda (a3)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.